Lopez-Bonet, E., Buxó, M., Cuyàs, E., Pernas, S., Dorca, J., Álvarez, I., & Cortés Castan, J. (2019). Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer.
Citação norma ChicagoLopez-Bonet, Eugeni, Maria Buxó, Elisabet Cuyàs, Sonia Pernas, Joan Dorca, Isabel Álvarez, y Javier Cortés Castan. Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer. 2019.
Citação norma MLALopez-Bonet, Eugeni, et al. Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer. 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.